These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23660969)

  • 21. [Screening measure for borderline personality disorder].
    Kröger C; Vonau M; Kliem S; Kosfelder J
    Psychother Psychosom Med Psychol; 2010; 60(9-10):391-6. PubMed ID: 20225166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of patients with borderline personality disorder in a state psychiatric hospital.
    Leontieva L; Gregory R
    J Pers Disord; 2013 Apr; 27(2):222-32. PubMed ID: 23514185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Psychopharmacotherapy improves psychosocial functioning in adolescents with borderline personality disorder].
    Wöckel L; Goth K; Zepf FD; Matic N; Holtmann M; Herpertz-Dahlmann B; Poustka F
    Prax Kinderpsychol Kinderpsychiatr; 2010; 59(4):282-301. PubMed ID: 20491428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy.
    Swartz HA; Pilkonis PA; Frank E; Proietti JM; Scott J
    Bipolar Disord; 2005 Apr; 7(2):192-7. PubMed ID: 15762861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life: the ultimate outcome measure of interventions in major depressive disorder.
    IsHak WW; Greenberg JM; Balayan K; Kapitanski N; Jeffrey J; Fathy H; Fakhry H; Rapaport MH
    Harv Rev Psychiatry; 2011; 19(5):229-39. PubMed ID: 21916825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
    CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment].
    Wöckel L; Goth K; Matic N; Zepf FD; Holtmann M; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):37-49. PubMed ID: 20047175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Borderline personality disorder in male and female offenders newly committed to prison.
    Black DW; Gunter T; Allen J; Blum N; Arndt S; Wenman G; Sieleni B
    Compr Psychiatry; 2007; 48(5):400-5. PubMed ID: 17707246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The process of managing medications in patients with borderline personality disorder.
    Silk KR
    J Psychiatr Pract; 2011 Sep; 17(5):311-9. PubMed ID: 21926526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication utilization patterns and methods of suicidality in borderline personality disorder.
    Makela EH; Moeller KE; Fullen JE; Gunel E
    Ann Pharmacother; 2006 Jan; 40(1):49-52. PubMed ID: 16303987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A relationship between bipolar II disorder and borderline personality disorder?
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1022-9. PubMed ID: 18313825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotherapists' response to borderline personality disorder: a core conflictual relationship theme analysis.
    Bourke ME; Grenyer BF
    Psychother Res; 2010 Nov; 20(6):680-91. PubMed ID: 20824574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacotherapy of borderline disorders. A review of the literature].
    Dulz B
    Nervenarzt; 1994 Nov; 65(11):755-61. PubMed ID: 7816151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary, randomized trial of psychoeducation for women with borderline personality disorder.
    Zanarini MC; Frankenburg FR
    J Pers Disord; 2008 Jun; 22(3):284-90. PubMed ID: 18540800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Borderline personality disorder in adolescents: evidence in support of the Childhood Interview for DSM-IV Borderline Personality Disorder in a sample of adolescent inpatients.
    Sharp C; Ha C; Michonski J; Venta A; Carbone C
    Compr Psychiatry; 2012 Aug; 53(6):765-74. PubMed ID: 22300904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quality of depression in borderline personality disorder and the diagnostic process.
    Silk KR
    J Pers Disord; 2010 Feb; 24(1):25-37. PubMed ID: 20205497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of Psychotropic Drug Therapy in Borderline Personality Disorder: a Case Report.
    Bradford R; Holt C
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S371-4. PubMed ID: 26417798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult attachment in the clinical management of borderline personality disorder.
    Fossati A
    J Psychiatr Pract; 2012 May; 18(3):159-71. PubMed ID: 22617081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic overlap between attention-deficit/hyperactivity disorder and borderline personality disorder in women: the role of temperament and character traits.
    van Dijk FE; Lappenschaar M; Kan CC; Verkes RJ; Buitelaar JK
    Compr Psychiatry; 2012 Jan; 53(1):39-47. PubMed ID: 21511251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial.
    Jørgensen CR; Freund C; Bøye R; Jordet H; Andersen D; Kjølbye M
    Acta Psychiatr Scand; 2013 Apr; 127(4):305-17. PubMed ID: 22897123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.